New Nordic Healthbrands AB said its first-quarter normalized net income amounted to 39 Swedish öre per share, an increase of 43.1% from 27 öre per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 2.4 million kronor, a gain of 43.1% from 1.7 million kronor in the prior-year period.
The normalized profit margin increased to 3.3% from 2.8% in the year-earlier period.
Total revenue climbed 19.4% year over year to 72.9 million kronor from 61.1 million kronor, and total operating expenses increased 18.8% year over year to 68.9 million kronor from 58.0 million kronor.
Reported net income rose 50.5% on an annual basis to 3.1 million kronor, or 50 öre per share, from 2.1 million kronor, or 33 öre per share.
As of April 29, US$1 was equivalent to 8.32 Swedish kronor.
